2型糖尿病患者新型冠状病毒肺炎流行期间心理状态及行为调查

doi:10.3969/j.issn.1006-7795.2020.06.017

摘要/Abstract

摘要： 目的调查2型糖尿病患者在新型冠状病毒肺炎流行期间的心理状态及行为改变,为更好地进行血糖管理和心理、行为指导提供依据。方法纳入首都医科大学附属北京潞河医院标准化代谢性疾病管理中心(National Metabolic Management Center,MMC)内 576名2型糖尿病患者,采用自编问卷结合焦虑、抑郁筛查量表开展横断面调查,并与同期未入MMC管理的2型糖尿病患者进行焦虑、抑郁发生率进行比较。结果在新型冠状病毒肺炎流行期间,68.4%的患者近2周指尖血糖浓度控制在空腹4.4~7.0 mmol/L、餐后2 h血糖10 mmol/L以下,69.1%的2型糖尿病患者运动量较前减少。MMC管理内的2型糖尿病患者的焦虑和抑郁发生率分别为27.1%和23.6%,低于同期未入MMC管理的患者,独居状态(OR=0.393,95%CI:0.160~0.965)、存在合并症或存在合并症个数多(OR=15.544, 95%CI:9.632~25.084)的患者发生焦虑症状的风险高(均P＜0.05);年龄较小(OR=0.541,95%CI:0.389~0.751)、独居患者(OR=0.398,95%CI:0.167~0.948)、存在合并症或合并症个数多(OR=7.409,95%CI:4.962~11.065)、血糖控制水平差(OR=0.659,95%CI: 0.506~0.859)的患者发生抑郁症状的风险较高(均P＜0.05)。结论在新型冠状病毒肺炎流行期,MMC管理的2型糖尿病患者焦虑、抑郁发生率较非MMC管理的患者低,多数患者血糖控制水平达标,对新型冠状病毒的认知较充分且行为以积极健康为主。

关键词: 新型冠状病毒肺炎, 2型糖尿病, 标准化代谢性疾病管理中心, 焦虑, 抑郁

Abstract: Objective To investigate the behavior changes and psychological fluctuation of patients with type 2 diabetes during theCOVID-19 pandemic period pandemic period, and to provide basis for better glucose management, psychological, behavioral guidance. Methods Totally 576 type 2 diabetic patients were subjected from the National Metabolic Management Center(MMC)in Beijing Luhe Hospital, based on the in-house questionnaires, Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder assessment (GAD-7) for the cross sectional analysis. The incidence of anxiety and depression was compared with that of type 2 diabetic patients who were not under MMC management during the same period. Results During 2019-nCoV pandemic period, 68.4% of the patients' fingertip glucose level was controlled well in the past two weeks, with fasting blood glucose at 4.4-7.0 mmol/L and 2-hour postprandial blood glucose below 10 mmol/L. 69.1% of type 2 diabetic patients had less physical exercise than before. The prevalence of anxiety and depression of the type 2 diabetic patients under the MMC management was 27.1% and 23.6%, respectively, lower than those without MMC management during the same period. Patients who lived alone(OR=0.393,95%CI:0.160-0.965), and who had one or more comorbidities (OR=15.544, 95%CI:9.632-25.084)were at high risk of anxiety(All P＜0.05). Those who were younger(OR=0.541, 95%CI: 0.389-0.751), lived alone(OR=0.398, 95%CI:0.167-0.948), had one or more comorbidities (OR=7.409, 95%CI:4.962-11.065),and had poor blood glucose control (OR=0.659, 95%CI:0.506-0.859) were at higher risk of depression(All P＜0.05). Conclusions During the epidemic period, the incidence of anxiety and depression in type 2 diabetic patients under MMC management was lower than that of patients not under MMC management, and blood glucose of the former was basically well controlled. The patients had a good knowledge of the 2019-nCoV. The cognition and behavior pattern of most patients managed by MMC were positive.

Key words: 2019-nCoV, type 2 diabetes, national metabolic management center, anxiety, depression

中图分类号:

R587

尹星琪, 于彩果, 柯静, 赵冬, 于可. 2型糖尿病患者新型冠状病毒肺炎流行期间心理状态及行为调查[J]. 首都医科大学学报, 2020, 41(6): 970-977.

Yin Xingqi, Yu Caiguo, Ke Jing, Zhao Dong, Yu Ke. A questionnaire survey on the mentality and behavior of patients with type 2 diabetes duringCOVID-19 pandemic period[J]. Journal of Capital Medical University, 2020, 41(6): 970-977.

参考文献

[1] 杨娟, 赖圣杰, 余宏杰. 感染性疾病流行现状、防控挑战与应对[J]. 中华疾病控制杂志, 2017,21(7):647-649, 674.
[2] 国家卫生健康委员会, 国家中医药管理局. 新型冠状病毒肺炎诊疗方案(试行第七版)[J]. 江苏中医药, 2020,52(4):1-6.
[3] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223):507-513.
[4] Ranganath M, Sriram G. COVID-19 pandemic, coronaviruses, and diabetes mellitus[J]. Am J Physiol Endocrinol Metab, 2020 318(5):E736-E741.
[5] World Health Orgnization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation, 2006[M]. Geneva: WHO Document Production Services, 2006.
[6] Kroenke K, Spitzer R L, Williams J B. The PHQ-9: validity of a brief depression severity measure[J]. J Gen Intern Med, 2001,16(9):606-613.
[7] Spitzer R L, Kroenke K, Williams J B, et al. A brief measure for assessing generalized anxiety disorder: the GAD-7[J]. Arch Intern Med, 2006,166(10):1092-1097.
[8] Qiu J, Shen B, Zhao M, et al. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations[J]. Gen Psychiatr, 2020,33(2):e100213.
[9] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study[J]. Lancet, 2020,395(10223):507-513.
[10]Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up[J]. J Infect, 2020,80(6):639-645.
[11]Furuya M, Hayashino Y, Tsujii S, et al. Comparative validity of the WHO-5 Well-Being Index and two-question instrument for screening depressive symptoms in patients with type 2 diabetes[J]. Acta Diabetol, 2013,50(2):117-121.
[12]Gois C J, Ferro A C, Santos A L, et al. Psychological adjustment to diabetes mellitus: highlighting self-integration and self-regulation[J]. Acta Diabetol, 2012,49(Suppl 1):S33-S40.
[13]冯艳春, 刘娜, 刘继霞, 等. 用 GAD-7和 PHQ-9调查分析综合医院住院患者的焦虑抑郁状况[J]. 齐齐哈尔医学院学报, 2015(32):4926-4927.
[14]吴金凤, 吴夏鑫, 李双, 等. 2型糖尿病患者焦虑、抑郁与血糖控制的关联及其临床护理[J]. 实用临床医药杂志, 2019,23(6):62-65.
[15]高兴,刘海燕,陈丽萍,等.老年2型糖尿病患者合并焦虑和抑郁的相关影响因素分析[J].解放军医药杂志,2019,31(12):77-80.
[16]Semenkovich K, Brown M E, Svrakic D M, et al. Depression in type 2 diabetes mellitus: prevalence, impact, and treatment[J]. Drugs, 2015,75(6):577-587.
[17]Shinkov A, Borissova A M, Kovatcheva R, et al. Increased prevalence of depression and anxiety among subjects with metabolic syndrome and known type 2 diabetes mellitus-a population-based study[J]. Postgrad Med, 2018,130(2):251-257.
[18]纪立农, 李光伟, 巩秋红, 等. 新型冠状病毒肺炎疫情期间老年糖尿病患者疾病管理与应急指引[J]. 中国糖尿病杂志, 2020,28(1):1-6.
[19]中国老年保健医学研究会老年内分泌与代谢病分会编写组. 新型冠状病毒肺炎疫情期间老年糖尿病患者疾病管理与应急指引[J]. 中国糖尿病杂志, 2020,28(1):1-6.
[20]Hashim N A, Ariaratnam S, Salleh M R, et al. Depression and associated factors in patients with type 2 diabetes mellitus[J]. East Asian Arch Psychiatr, 2016,26(2):77-82.
[21]Arshad A R, Alvi K Y. Frequency of depression in type 2 diabetes mellitus and an analysis of predictive factors[J]. J Pak Med Assoc, 2016,66(4):425-429.
[22]AlBekairy A, AbuRuz S, Alsabani B, et al. Exploring factors associated with depression and anxiety among hospitalized patients with type 2 diabetes mellitus[J]. Med Princ Pract, 2017,26(6):547-553.